The Comparative Efficacy of Imipenem and Meropenem On Different Bacterial Strains Obtained from Clinical Samples
Imipenem and Meropenem On Different Bacterial Strains
DOI:
https://doi.org/10.54393/pjhs.v3i05.156Keywords:
Antibiotic Resistance, Carbapenem, Imipenem, Meropenem, P. aerugionosaAbstract
The most serious threat to patient's and the public's health is the resistance of clinically relevant microorganisms to antimicrobials. Objective: This study's primary objective was to compare the susceptibility profiles of imipenem and meropenem on various bacterial strains. Methods: 101 distinct patients' positive samples of blood and pus were collected and sent to a pathology lab in Lahore (Mughal Diagnostic and Research laboratory Lahore). On Macconkey, CLED, and Blood Agar media, five bacterial strains; E. coli, P. aeruginosa, Enterococcus species, Klebsiella species and S. typhi were isolated and resurrected. Following microscopical (gram staining) and biochemical tests to identify these bacterial strains, the antibiotic sensitivity of these bacterial strains was assessed. Results: The findings of this investigation clearly demonstrated that imipenem is more sensitive than meropenem. Imipenem demonstrated improved sensitivity to all of the bacterial strains included in the study, especially E. coli, P. aeruginosa, various Enterococcus, Klebsiella, and S. typhi, imipenem showed a sensitivity of 84.15%, while meropenem showed a sensitivity of 40.59%. Conclusions: The current investigation came to the conclusion that antibiotics (imipenem and meropenem) are becoming more resistant to bacteria as a result of their growing and frequent use. Physicians started to worry about the developing antibiotic resistance due to the indiscriminate use of these treatments after more than a decade of increased antibiotic consumption in the era
References
Nathan C and Cars O. Antibiotic resistance--problems, progress, and prospects. The New England journal of medicine. 2014 Nov; 371(19):1761-3. doi: 10.1056/NEJMp1408040.
Davies J and Davies D. Origins and evolution of antibiotic resistance. Microbiology and Molecular Biology Reviews. 2010 Sep;74(3):417-33. doi: 10.1128/MMBR.00016-10
Roca I, Akova M, Baquero F, Carlet J, Cavaleri M, Coenen S, Cohen J, et al. The global threat of antimicrobial resistance: science for intervention. New Microbs and New Infections. 2015 Apr; 6:22-9. doi: 10.1016/j.nmni.2015.02.007.
Erbay H, Yalcin AN, Serin S, Turgut H, Tomatir E, Cetin B, et al. Nosocomial infections in intensive care unit in a Turkish university hospital: a 2-year survey. Intensive Care Medicine. 2003 Sep; 29(9):1482-8. doi: 10.1007/s00134-003-1788-x.
Aly NY, Al-Mousa HH, Al Asar el SM. Nosocomial infections in a medical-surgical intensive care unit. Medical Principles and Practice. 2008;17(5):373-7. doi: 10.1159/000141500.
Neidell MJ, Cohen B, Furuya Y, Hill J, Jeon CY, Glied S, et al. Costs of healthcare- and community-associated infections with antimicrobial-resistant versus antimicrobial-susceptible organisms. Clinical Infectious Diseases. 2012 Sep; 55(6):807-15. doi: 10.1093/cid/cis552.
Gupta K, Hooton TM, Stamm WE. Increasing antimicrobial resistance and the management of uncomplicated community-acquired urinary tract infections. Annals of internal medicine. 2001 Jul; 135(1):41-50. doi: 10.7326/0003-4819-135-1-200107030-00012.
Akram HM, Abdullahi NH, Dya EM. Extended spectrum beta lactamases among multi drug resistant Escherichia coli and Klebsiella species causing urinary tract infections in Khartoum. African Journal of Bacteriology Research. 2010 Aug; 2(3):18-21.
Mero WM. Phenotypic and Molecular Study of Extended-Spectrum β-lactamases Producing Enterobacteriaceae from Urinary Tract Infection in Zakho city, Kurdistan Region/Iraq. Academic Journal of Nawroz University. 2022 Aug; 11(3):305-13.
doi.10.25007/ajnu.v11n3a1447
Torres JA, Villegas MV, Quinn JP. Current concepts in antibiotic-resistant gram-negative bacteria. Expert Review of Anti-infective Therapy.2007 Oct; 5(5):833-43. doi: 10.1586/14787210.5.5.833.
Buckingham SC, McCullers JA, Luján-Zilbermann J, Knapp KM, Orman KL, English BK. Pneumococcal meningitis in children: relationship of antibiotic resistance to clinical characteristics and outcomes. Journal of pediatric infectious diseases. 2001 Sep; 20(9):837-43. doi: 10.1097/00006454-200109000-00003.
Zhanel GG, Wiebe R, Dilay L, Thomson K, et al. Comparative review of the carbapenems. Drugs. 2007; 67(7):1027-52. doi: 10.2165/00003495-200767070-00006.
Angkasekwinai N, Werarak P, Tongsai S, Thamlikitkul V. Effectiveness and safety of generic formulation of meropenem (Penem) for treatment of infections at Siriraj Hospital. Journal of the Medical Association of Thailand = Chotmaihet thangphaet. 2012 Feb; 95(Suppl 2): S34-41.
Wayne PA. Clinical and laboratory standards institute. Performance standards for antimicrobial susceptibility testing 2011.
Hellinger WC and Brewer NS. Carbapenems and monobactams: imipenem, meropenem, and aztreonam. Mayo Clinic Proceedings. 1999 Apr; 74(4):420-34. doi: 10.4065/74.4.420.
Ali N, Hameed A, Siddiqui M, Ghumro PB, Ahmed S. Application of Aspergillus niger SA1 for the enhanced bioremoval of azo dyes in simulated textile effluent. African Journal of Biotechnology. 2009; 8(16).
Khorvash F, Mostafavizadeh K, Mobasherizadeh S. Frequency of mecA gene and borderline oxacillin resistant Staphylococcus aureus in nosocomial acquired methicillin resistance Staphylococcus aureus infections. Pakistan Journal of Biological Sciences. 2008 May; 11(9):1282-5. doi: 10.3923/pjbs.2008.1282.1285.
Farhat U, Salman AM, Jawad A. Antimicrobial susceptibility pattern and ESBL prevalence in Klebsiella pneumoniae from urinary tract infections in the North-West of Pakistan. African journal of microbiology research. 2009 Nov; 3(11):676-80.
Mohammed MA, Alnour TM, Shakurfo OM, Aburass MM. Prevalence and antimicrobial resistance pattern of bacterial strains isolated from patients with urinary tract infection in Messalata Central Hospital, Libya. Asian Pacific journal of tropical medicine. 2016 Aug; 9(8):771-6. doi: 10.1016/j.apjtm.2016.06.011.
Riera E, Cabot G, Mulet X, García-Castillo M, del Campo R, Juan C, et al. Pseudomonas aeruginosa carbapenem resistance mechanisms in Spain: impact on the activity of imipenem, meropenem and doripenem. Journal of Antimicrobial Chemotherapy. 2011 Sep; 66(9):2022-7. doi: 10.1093/jac/dkr232.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Pakistan Journal of Health Sciences
This work is licensed under a Creative Commons Attribution 4.0 International License.
This is an open-access journal and all the published articles / items are distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. For comments